Maxitrol Suspension
Product Images NDC 82667-100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Maxitrol (NDC 82667-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Harrow Eye, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Maxitrol-suspension-01.jpg (Maxitrol Suspension 01)

Maxitrol-suspension-01.jpg (Maxitrol Suspension 01)
Chemical structure diagram of dexamethasone, one of the active ingredients in Maxitrol ophthalmic suspension. The structure shows molecular bonds and functional groups characteristic of dexamethasone.*
FDA Label Image

The Structural Formula For Neomycin Sulfate (Maxitrol Suspension 02)

The Structural Formula For Neomycin Sulfate (Maxitrol Suspension 02)
Chemical structure diagram of neomycin sulfate, showing its molecular components and structural connections as represented in the product’s active ingredients.*
FDA Label Image

The Structural Formula For Polymyxin B Sulfate (Maxitrol Suspension 03)

The Structural Formula For Polymyxin B Sulfate (Maxitrol Suspension 03)
Chemical structure diagram depicting the synthesis pathway of 2,4-diaminobutanoic acid (DAB) derivatives, showing transformations involving L-DAB, L-Thr, and other intermediates. A table lists variations of polymyxin components (B1, B2, B3, B1-I) with their corresponding R, R', and X groups, including L-Leu and L-Ile substitutions.*
FDA Label Image

Maxitrol-suspension-04.jpg (Maxitrol Suspension 04)

Maxitrol-suspension-04.jpg (Maxitrol Suspension 04)
The image shows the packaging label for Maxitrol, an ophthalmic suspension containing neomycin sulfate, polymyxin B sulfate, and dexamethasone. The label highlights its prescription-only status and includes usage precautions. The 5 mL sterile suspension is manufactured for Harrow Eye, LLC. The label also features barcodes and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.